Quadrant Capital Group LLC Regenxbio Inc. Transaction History
Quadrant Capital Group LLC
- $1.42 Billion
- Q3 2024
A detailed history of Quadrant Capital Group LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 1,812 shares of RGNX stock, worth $13,807. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,812
Previous 593
205.56%
Holding current value
$13,807
Previous $6,000
216.67%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RGNX
# of Institutions
196Shares Held
43MCall Options Held
104KPut Options Held
478K-
Black Rock Inc. New York, NY8.61MShares$65.6 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.89MShares$37.3 Million3.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.37MShares$33.3 Million0.0% of portfolio
-
State Street Corp Boston, MA2.78MShares$21.2 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.48MShares$18.9 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $329M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...